Search Within

Hematology-Oncology Fellows

Formats
  1. Meeting Abstract (636)
  2. Journal Article (504)
  3. Review (142)
  4. Editorial (64)
  5. Research Letter (50)
  6. Correspondence (14)
  7. Guidelines (6)
  8. Book Section (3)
  9. Conference Paper (2)
  10. Miscellaneous (2)
Groups
  1. Department of Medicine (1159)
  2. Graduate Medical Education (1116)
  3. GME, Medicine (1092)
  4. Hematologic Malignancies, Division of (747)
  5. Weinberg Fellows (657)
  6. Solid Tumor Oncology Division (614)

More Groups

People
  1. Jan Bewersdorf (102)
  2. Zachary Epstein-Peterson (93)
  3. Gunjan Shah (92)
  4. Maria Palomba (92)
  5. Gilles Salles (87)
  6. Michael Scordo (86)

More People

Years
  1. 2025 (159)
  2. 2024 (357)
  3. 2023 (296)
  4. 2022 (222)
  5. 2021 (159)
  6. 2020 (114)

More Years

Publications
  1. Blood (287)
  2. Journal of Clinical Oncology (219)
  3. Clinical Cancer Research (38)
  4. Annals of Oncology (35)
  5. Cancer Research (35)
  6. Journal of Thoracic Oncology (30)

More Publications

Publishers
  1. American Society of Hematology (322)
  2. American Society of Clinical Oncology (251)
  3. Elsevier Inc. (142)
  4. Nature Publishing Group (107)
  5. American Association for Cancer Research (104)
  6. Oxford University Press (61)

More Publishers

Results (1423)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Childhood and adolescent cancer survivors
    Book Section

    Valtis, Y. K.; Overholser, L. S.; Nekhlyudov, L.
    In Kuo, A. A.; Pilapil, M.; DeLaet, D. E.; Peacock, C.; Sharma, N. (Eds.) Care of Adults with Chronic Childhood Conditions: A Practical Guide. 2nd ed (2024)

    Fulltext@MSK | Save
  • Differences in ancestry and presence of gastric precursor lesions in individuals with young- and average-onset gastric cancer
    Journal Article

    Magahis, P. T.; Cornet, N.; Tang, L.; Arora, K.; Hingorani, N.; King, S.; Markowitz, A. J.; Schattner, M.; Shimada, S.; Maron, S. B.; more...
    Cancer Medicine (2024)

    Fulltext@MSK | Save
  • A novel JAK2 fusion in T-cell prolymphocytic leukemia
    Meeting Abstract

    Eren, O. C.; Stuver, R.; Zhou, T.; Zaidinski, M.; Moskowitz, A. J.; Horwitz, S. M.; Ewalt, M. D.; Zhang, Y.; Lim, M.
    Virchows Archiv (2024)

    Fulltext@MSK | Save
  • Defining the rates of cytokine release syndrome associated with Talquetamab step-up doses
    Meeting Abstract

    Hamadeh, I.; Shekarkhand, T.; Rueda, C.; Firestone, R.; Wang, A.; Korde, N.; Hultcrantz, M.; Lesokhin, A.; Mailankody, S.; Hassoun, H.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save
  • Comprehensive genomic sequencing predicts sub-optimal response to bispecific antibodies (BsAb) and chimeric antigen receptor T cells (CAR-T) in multiple myeloma (MM)
    Meeting Abstract

    Maclachlan, K.; Shekarkhand, T.; Farzana, T.; Costa, B.; Firestone, R.; Jurgens, E.; Rajeeve, S.; Hashmi, H.; Hassoun, H.; Shah, U.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save
  • Increased WEE1 expression is predictive of short progression-free survival, independent of standard prognostic factors in multiple myeloma
    Meeting Abstract

    Simhal, A.; Firestone, R.; Oh, J. H.; Norton, L.; Usmani, S.; Deasy, J.; Maclachlan, K.
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save
  • Impact of granulocyte colony-stimulating factor exposure on cytokine release syndrome during bispecific antibody initiation in relapsed/refractory multiple myeloma
    Meeting Abstract

    Wang, A.; Shekarkhand, T.; Derkach, A.; Nemirovsky, D.; Tan, C.; Hamadeh, I.; Firestone, R.; Jurgens, E.; Miller, K.; Korde, N.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save
  • Incidence and clinical impact of acute kidney injury: A comparison of CAR T-cell and bispecific antibody therapies
    Meeting Abstract

    Nishimura, N.; Mailankody, S.; Nemirovsky, D.; Derkach, A.; Costa, B.; Farzana, T.; Jurgens, E.; Firestone, R.; Nath, K.; Chung, D.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save
  • Phase I trial of MCARH109, a first-in-class G Protein Coupled Receptor Class C Group 5 Member D (GPRC5D)-targeted CAR T-cell therapy for relapsed or refractory multiple myeloma: Updated analysis
    Meeting Abstract

    Jurgens, E.; Firestone, R.; Chaudhari, J.; Hosszu, K.; Devlin, S.; Shah, U.; Landa, J.; McAvoy, D.; Lesokhin, A.; Korde, N.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save
  • CMV reactivation during treatment with bispecific antibodies for relapsed/refractory multiple myeloma
    Meeting Abstract

    Jurgens, E.; Shekarkhand, T.; Rueda, C.; Nemirovsky, D.; Derkach, A.; Firestone, R.; Miller, K.; Costa, B.; Rajeeve, S.; Lesokhin, A.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save